The Oncology Information Systems Market is projected to reach $4.45 billion by 2030, at a CAGR of 7.4% from 2024 to 2030. An oncology information system (OIS) is a software solution used to manage all aspects of cancer care, such as patient treatment schedules, treatment plans, treatment delivery, treatment summaries, and results. It differs from other types of information systems by its design and purpose, as it is specifically intended for managing cancer patients. It collects long-term patient data from patient history to various phases of treatments, diagnostic imaging, palliative care, and end-of-life care.
The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, rising need to reduce oncology care costs, increasing adoption of electronic health records (EHR), and increased demand for streamlined patient information and data management. In addition, the integration of precision medicine for cancer treatment and its potential in emerging countries are expected to provide significant growth opportunities for this market.
However, the high cost of oncology information systems and data security and privacy concerns are expected to restrain the growth of this market to a certain extent. In addition, factors such as barriers to adoption and implementation and additional requirement for training and education for using oncology information systems pose major challenges to the market’s growth.
The Increasing Prevalence of Cancer is Driving the Oncology Information Systems Market
Cancer has been one of the most complex and expensive diseases globally, with a huge economic burden on many countries. The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetimes, with 1 in 8 men and 1 in 11 women dying from the disease.
Cancer is a major cause of death and a prominent obstacle to improving life expectancy in every country worldwide. According to the International Agency for Research on Cancer (IARC), the number of new cancer cases is expected to increase from 19.2 million in 2020 to 24.5 million by 2030. In addition, mortalities from cancer are expected to increase from 9.9 million in 2020 to 12.9 million by 2030.
Early disease diagnosis and effective treatment can help decrease cancer mortality rates. As cancer treatment takes a long time, providing effective treatment can be improved by optimizing data collection and analysis. Oncology information systems support cancer care by collecting patient data during various stages of cancer care, including screening, prevention, diagnosis, treatment, palliative care, and end-of-life care. It helps streamline patient data and supports clinical decision-making. The rising prevalence of cancer is expected to drive the demand for oncology information systems.
Click here to: Get a Free Sample Copy of this Report
Rising Need to Reduce Oncology Care Costs to Drive Demand for Oncology Information Systems
The diagnosis, medication, and treatment for cancer is very costly since it requires treatment through surgery, radiotherapy, and chemotherapy. Owing to the high cost of cancer treatment, it causes an economic burden on countries. According to a study published in the JAMA Oncology journal, the global economic cost of cancers from 2020 to 2050 was estimated to be USD 25.2 trillion. The U.S. and China are estimated to face the largest economic burden of cancer. Hence, there is a rising need to reduce oncology care costs.
Oncology information systems can improve cancer care by improving documentation, optimizing resource allocation, and increasing cancer care's cost-effectiveness. Various professionals are involved in the care, such as oncologists, pathologists, radiologists, pharmacists, and laboratory technicians. Due to this, the adoption of oncology information systems reduces errors and increases data accuracy & efficiency through automating activities.
Thus, the rising need to reduce oncology care costs is expected to drive the demand for high adoption of oncology information systems in the coming years.
Key Findings of the Oncology Information Systems Market Study:
In 2024, the Software Segment is Expected to Dominate the Oncology Information Systems Market
Based on offerings, the oncology information systems market is segmented into software and services. In 2024, the software segment is expected to account for the largest share of the oncology information systems market. The large share of this segment is attributed to the factors such as the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.
In 2024, the Medical Oncology Segment is Expected to Dominate the Oncology Information Systems Market
Based on application, the oncology information systems market is segmented into medical oncology, radiation oncology, and surgical oncology. In 2024, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.
In 2024, the Hospitals Segment is Expected to Dominate the Oncology Information Systems Market
Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2024, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement an oncology information system, and increased number of cancer patients.
Asia-Pacific: The Fastest-growing Regional Market
Asia-Pacific is slated to record the highest CAGR in the oncology information systems market during the forecast period. The growth of this regional market is driven by the increasing number of oncology specialty hospitals, increasing awareness about health information systems (HIS), and increasing volume of patient data in the region.
Key Players
The report includes a competitive landscape based on an extensive assessment of the market based on offering, application, end user, and geography. The report also provides insights into the geographic presence of major market players and the key growth strategies adopted by them in the last three to four years.
The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).
Scope of the Report:
Oncology Information Systems Market Assessment, by Offering
- Software
- Patient Information Systems
- Treatment Planning Systems
- Services
Oncology Information Systems Market Assessment, by Application
- Radiation Oncology
- Medical Oncology
- Surgical Oncology
Oncology Information Systems Market Assessment, by End User
- Hospitals
- Diagnostic Imaging Centers
- Cancer Care Centers
- Other End Users
(Note:Other end users primarily include research institutes and government institutions, among others)
Oncology Information Systems Market Assessment, by Geography
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Middle East & Africa
Key questions answered in the report:
